Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03193970 · ClinicalTrials.gov registry record
Measuring Surgical Recovery After Radical Cystectomy
A clinical trial of Bladder Cancer, sponsored by M.D. Anderson Cancer Center.
- Recruiting
- Registry status
- 2,000
- Enrollment target
- 11
- Study locations
NCT03193970: Recruiting study of Bladder Cancer, sponsored by M.D. Anderson Cancer Center.
NCT03193970 is a study of Bladder Cancer that is actively recruiting participants, run by M.D. Anderson Cancer Center. The registered enrollment target is 2,000 participants, below the 12,742-participant average among 175 other Bladder Cancer trials with a reported enrollment target (84% lower). The trial reports 11 study locations across 8 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03193970, a study of Bladder Cancer, is actively recruiting participants, sponsored by M.D. Anderson Cancer Center.
- RECRUITING
- Registry status
- 2,000 participants
- Enrollment target
- 11
- Study locations
Study Summary
The intent of this study is to establish a registry of post-surgical outcomes in patients undergoing radical cystectomy at MD Anderson Cancer Center and the collaborating institutions. The goals of this initiative are to obtain a detailed baseline of multiple patient-reported outcomes (PRO) and clinician-reported outcomes (CRO) as well as various presenting conditions associated with them, so that future quality improvement interventions can be evaluated accurately as to their relative contribution to improved outcomes.
Primary Outcome
Post-surgical outcomes determined from patient-reported assessment of symptom burden using the MD Anderson Symptom Inventory (MDASI-BLC form).
Conditions Studied
Interventions
- BEHAVIORAL Post-Operative Recovery Registry
Study Locations (11)
California
- University of California - San Francisco - San Francisco
- Stanford University - Stanford
New York
- Winthrop University Hospital - Mineola
- University of Rochester - Rochester
Texas
- University of Texas - Southwestern - Dallas
- University of Texas MD Anderson Cancer Center - Houston
Georgia
- Emory University - Atlanta
Illinois
- University of Chicago - Chicago
Kansas
- University of Kansas Medical Center - Lawrence
Maryland
- John Hopkins Medical Institutions - Baltimore
Michigan
- Spectrum Health Medical Group - Grand Rapids
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,000 participants |
| Start Date | 2015-04-30 |
| Est. Completion | 2034-12-31 |
What NCT03193970 shows while recruiting
NCT03193970 is an observational study that tracks outcomes without assigning an intervention. Its 2,000 participants enrollment target places it among the larger protocols in the corpus, below the 12,742-participant average among 175 other Bladder Cancer trials with a reported enrollment target (84% lower).
The record links to 1 condition, with Bladder Cancer appearing as the primary indexed condition, and to 1 intervention - of which Post-Operative Recovery Registry is the first listed.
NCT03193970 lists 11 locations in 8 states (California, New York, Texas).
Frequently Asked Questions
What is clinical trial NCT03193970 about?
NCT03193970 is a clinical study titled "Measuring Surgical Recovery After Radical Cystectomy". The intent of this study is to establish a registry of post-surgical outcomes in patients undergoing radical cystectomy at MD Anderson Cancer Center and the collaborating institutions. The goals of this initiative are to obtain a detailed baseline of multiple patient-reported outcomes (PRO) and clin...
What is the current status of trial NCT03193970?
This trial is currently recruiting. The enrollment target is 2,000 participants. The study started on 2015-04-30. Estimated completion is 2034-12-31.
What conditions does trial NCT03193970 study?
This clinical trial studies the following conditions: Bladder Cancer.
What interventions are being tested in trial NCT03193970?
The interventions under investigation include: Post-Operative Recovery Registry (BEHAVIORAL).
Who is sponsoring clinical trial NCT03193970?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03193970 being conducted?
This trial has 11 study locations across California, Georgia, Illinois, Kansas, Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Bladder Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03193970's enrollment target sits among peer trials
2,000 11th of 175 higher than 164 of 175 other Bladder Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Bladder Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas.
RECRUITING · Phase 1
-
Home Intravenous Fluid Infusion After Undergoing Radical Cystectomy
RECRUITING · NA
-
KEYMAKER-U04 Substudy 04D: A Clinical Study of New Treatments Given With Enfortumab Vedotin and Pembrolizumab in People With Urothelial Cancer (MK-3475-04D/KEYMAKER-U04)
RECRUITING · Phase 1
-
CONFIRM: Magnetic Resonance Guided Radiation Therapy
RECRUITING · NA
-
Intravesical Treatment of Bladder Cancer at Home, Multi-modal Treatment Support
RECRUITING · NA
-
Improving Care for Rural Patients With Solid Tumors
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001465 · 2,000 participants
Study of the Disease Process of Lymphangioleiomyomatosis
- NCT00001595 · 2,000 participants
An Investigation of Pituitary Tumors and Related Hypothalmic Disorders
- NCT00138931 · 2,000 participants
Genetics of Cardiovascular and Neuromuscular Disease
- NCT00288119 · 2,000 participants
Genetic Determinants of Barrett's Esophagus and Esophageal Adenocarcinoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI